Isobutylhydroxyamides from the pericarp of Nepalese Zanthoxylum armatum inhibit NF1-defective tumor cell line growth.

J Nat Prod

Molecular Targets Laboratory, Center for Cancer Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, USA.

Published: January 2013

A neurofibromatosis type 1 (NF1)-based bioassay-guided phytochemical investigation on Zanthoxylum armatum collected in Nepal led to the isolation of new timuramides A-D (1-4) and six known sanshools (5-10). The structures of all compounds were established by using modern spectroscopic techniques, including 1D and 2D NMR analysis and comparison with previously reported data. Most of the compounds inhibited growth of an Nf1- and p53-deficient mouse glioma cell line at noncytotoxic concentrations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556213PMC
http://dx.doi.org/10.1021/np300696gDOI Listing

Publication Analysis

Top Keywords

zanthoxylum armatum
8
isobutylhydroxyamides pericarp
4
pericarp nepalese
4
nepalese zanthoxylum
4
armatum inhibit
4
inhibit nf1-defective
4
nf1-defective tumor
4
tumor cell
4
cell growth
4
growth neurofibromatosis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!